Scientists have long suspected that hormones quietly tune how the brain learns, but the idea of a single, hidden “switch” has ...
New subgroup analysis from the Phase 3 monarchE trial that explores outcomes by nodal status for Verzenio plus endocrine therapy in HR+, HER2– high-risk early breast cancer INDIANAPOLIS, Nov. 24, 2025 ...